Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

Investor Relations

AGEN Stock - Agenus Stock Trading

home / stock / agen

AGEN AGEN Quote AGEN Short AGEN News AGEN Articles AGEN Message Board

About | Agenus Inc. (NASDAQ:AGEN)

Agenus Inc is an American biotechnology company. Its main target is immuno-oncology treatments. The company's portfolio consists of therapeutic antibodies and vaccines to treat immuno-oncology illnesses: cancers, shingles, malaria, glioblastoma, and others. Agenus treatments aim, by combining multiple antibody platforms, to stimulate the immune system to recognize and fight cancer cells. The company has been cooperating with companies like Incyte, Merck Sharpe & Dohme, and Recepta Biopharma to achieve over a dozen antibody programs. Some of its products include Prophage, AutoSynVax, QS-21 Stimulon, and others.

Quote | Agenus Inc. (NASDAQ:AGEN)

Last:$1.64
Change Percent: -3.11%
Open:$1.66
Close:$1.64
High:$1.67
Low:$1.55
Volume:471,266
Last Trade Date Time:03/24/2025 03:00:00 am

News | Agenus Inc. (NASDAQ:AGEN)

  • Agenus (AGEN) Q4 2024 Earnings Call Transcript

    2025-03-11 11:45:16 ET Image source: The Motley Fool. Agenus (NASDAQ: AGEN) Q4 2024 Earnings Call Mar 11, 2025 , 8:30 a.m. ET Operator Continue reading

    • March 11, 2025 11:45:16 am

    • |
    • Motley Fool
    • |
      • AGEN Stock
      • AGEN Quote
      • AGEN Short
      • AGEN News
      • AGEN Articles
      • AGEN Message Board
  • Agenus stock falls after revenue miss

    2025-03-11 11:40:36 ET More on Agenus Agenus Inc. (AGEN) Q4 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on Agenus Historical earnings data for Agenus Financial information for Agenus Read the full article on Seeking Alpha ...

    • March 11, 2025 11:40:36 am

    • |
    • SeekingAlpha
    • |
      • AGEN Stock
      • AGEN Quote
      • AGEN Short
      • AGEN News
      • AGEN Articles
      • AGEN Message Board

Message Board Posts | Agenus Inc. (NASDAQ:AGEN)

Subject By Source When
whytestocks: $AGEN News Article - Agenus Selected for Late-Breaking Oral Presentation at ESMO-GI whytestocks investorshangout 05/03/2023 6:35:51 PM
shalbyj: TheStreetReports: AI Biotech Stocks to Watch 2023: $IPA, $ONTX, $AGEN, $PBIO https://www.ma shalbyj investorshangout 04/25/2023 1:37:15 PM
whytestocks: $AGEN News Article - Agenus Receives Fast Track Designation for Botensilimab and Balsti whytestocks investorshangout 04/17/2023 12:00:59 PM
whytestocks: $AGEN News Article - Agenus' Botensilimab in Combination with Balstilimab Shows 33% Dur whytestocks investorshangout 03/27/2023 3:10:50 PM
whytestocks: $AGEN News Article - Best Penny Stocks To Buy Now: 3 To Watch Before Next Week whytestocks investorshangout 03/15/2023 8:20:47 PM
Stock Information
Get AGEN Alerts

News, Short Squeeze, Breakout and More Instantly...

Agenus Inc. Company Name:

AGEN Stock Symbol:

NASDAQ Market:

-3.11% G/L:

$1.64 Last:

471,266 Volume:

$1.66 Open:

$1.64 Close:

Agenus Inc. Website:

Agenus Inc. Logo

Ad

Investor Relations
RECENT AGEN NEWS
  • AGEN - Agenus (AGEN) Q4 2024 Earnings Call Transcript

    2025-03-11 11:45:16 ET Image source: The Motley Fool. Agenus (NASDAQ: AGEN) Q4 2024 Earnings Call Mar 11, 2025 , 8:30 a.m. ET Operator Continue reading

  • AGEN - Expected US Company Earnings on Tuesday, March 11th, 2025

    Algoma Steel Group Inc. (ASTL) is expected to report $0.06 for Q3 2025 E.W. Scripps Company (The) (SSP) is expected to report for Q4 2024 TransAct Technologies Incorporated (TACT) is expected to report $-0.1 for Q4 2024 Kindly MD, Inc. (KDLY) is expected to report for Q4 2024 Talo...

  • AGEN - Agenus to Participate in B. Riley Securities Precision Oncology & Radiopharma Investor Conference

    Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today announced participation in a panel discussion at the B. Riley Securities Precision Oncology & Radiopharma Investor Conference that will take place on Friday, February 28th in New York. Panel Discussion Details: Speak...

  •
  • Research
  • Stock Search
  • News Releases
  • Articles
  • Topics
  • Message Boards
  • Trending Stocks
  • Trending Feed
  • Trending Alerts
  • Watchlist
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your X Account

Link your X Account to Market Wire News

When you linking your X Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your X account.

Be alerted of any news about your stocks and see what other stocks are trending.

Trending Stock Alerts

Trending Stock Alerts

Our Next Stock Alert could be Coming in Minutes!

Sign Up Today To Get Full Access To Our Next Stock Report!

  • Day Before Email and Text Notifications of New Alerts
  • Day of Email and Text Notifications
  • Trending Stocks, Watchlist and News Releases
  • Mobile App Notifications
Trending Stock Alerts

Get AGEN Alerts

Get AGEN Alerts

News, Short Squeeze, Breakout and More Instantly...

Sign up or login to continue

Sign up or login to continue.

Forgot password?


Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.

Disclaimer

This electronic content is for the purposes of solicitation subscriptions for Market Wire News. Market Wire News expects to generate new advertisement revenue resulting from the distribution of this electronic content. The amount of which is unknown at this time. Market Wire News is not a registered investment adviser or broker-dealer. This electronic content does not provide a professional analysis of a any stock financial position. any stock's financial position and all other information regarding the featured Company should be verified directly with any stock. This electronic content is provided as an information service only, and any statements and opinions in this electronic content should not be construed as an offer or solicitation to buy or sell any security. Market Wire News accepts no liability for any loss arising from an investor's reliance on or use of this electronic content. An investment in any company is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Market Wire News does not own, buy, sell or plans to own, buy, sell, and of any stock's shares. This electronic content contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Please read our full disclaimer for compensation and more detailed information.

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

| X

| Facebook

| BlueSky

| LinkedIn

| Telegram

| Discord

Contact

Privacy

Terms of Service

Disclaimer

© 2025 Market Wire News 1